BIOMARKER:

EGFR-RAD51 fusion

Entrez ID:

Related biomarkers:

‹

›

EGFR-RAD51 fusion EGFR-RAD51 fusion	Lung Adenocarcinoma LUAD	EGFR-RAD51 fusion EGFR-RAD51 fusion	Lung Adenocarcinoma LUAD	EGFR inhibitor Resistant: C3 – Early Trials	EGFR inhibitor Resistant: C3 – Early Trials
EGFR-RAD51 fusion EGFR-RAD51 fusion	Lung Adenocarcinoma LUAD	EGFR-RAD51 fusion EGFR-RAD51 fusion	Lung Adenocarcinoma LUAD	icotinib Sensitive: C4 – Case Studies	icotinib Sensitive: C4 – Case Studies
EGFR-RAD51 fusion EGFR-RAD51 fusion	Non Small Cell Lung Cancer NSCLC	EGFR-RAD51 fusion EGFR-RAD51 fusion	Non Small Cell Lung Cancer NSCLC	erlotinib Sensitive: C4 – Case Studies	erlotinib Sensitive: C4 – Case Studies
EGFR-RAD51 fusion EGFR-RAD51 fusion	Non Small Cell Lung Cancer NSCLC	EGFR-RAD51 fusion EGFR-RAD51 fusion	Non Small Cell Lung Cancer NSCLC	gefitinib Sensitive: C4 – Case Studies	gefitinib Sensitive: C4 – Case Studies
EGFR-RAD51 fusion EGFR-RAD51 fusion	Non Small Cell Lung Cancer NSCLC	EGFR-RAD51 fusion EGFR-RAD51 fusion	Non Small Cell Lung Cancer NSCLC	erlotinib + osimertinib Sensitive: C4 – Case Studies	erlotinib + osimertinib Sensitive: C4 – Case Studies